Trials / Completed
CompletedNCT06934980
A Study to Evaluate Microneedle-based Collection of Dermal Interstitial Skin Fluid in Healthy Participants and Atopic Dermatitis Participants
A PHASE 0, EVALUATION OF MICRONEEDLE-BASED COLLECTION OF DERMAL INTERSTITIAL SKIN FLUID IN HEALTHY PARTICIPANTS AND ATOPIC DERMATITIS PATIENTS
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- Incyte Corporation · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate microneedle-based collection of dermal interstitial skin fluid (dISF) in healthy participants and atopic dermatitis (AD) participants
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Microneedle Device | Microneedle device will be used for collecting dermal interstitial skin fluid samples as defined by the protocol. |
Timeline
- Start date
- 2025-06-27
- Primary completion
- 2025-12-19
- Completion
- 2025-12-19
- First posted
- 2025-04-18
- Last updated
- 2026-01-16
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06934980. Inclusion in this directory is not an endorsement.